These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 11166003)
1. Current approaches to reducing gastrointestinal toxicity of low-dose aspirin. Lanas AI Am J Med; 2001 Jan; 110(1A):70S-73S. PubMed ID: 11166003 [TBL] [Abstract][Full Text] [Related]
2. Treatment and prevention of aspirin-induced gastroduodenal ulcers and gastrointestinal bleeding. Lanas A; Ferrández A Expert Opin Drug Saf; 2002 Sep; 1(3):245-52. PubMed ID: 12904140 [TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Graham DY Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000 [TBL] [Abstract][Full Text] [Related]
4. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Goldstein JL; Huang B; Amer F; Christopoulos NG Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480 [TBL] [Abstract][Full Text] [Related]
5. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy. Iwamoto J; Saito Y; Honda A; Matsuzaki Y World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156 [TBL] [Abstract][Full Text] [Related]
6. Does adding misoprostol to standard intravenous proton pump inhibitor protocol improve the outcome of aspirin/NSAID-induced upper gastrointestinal bleeding?: a randomized prospective study. Yilmaz S; Bayan K; Dursun M; Canoruç F; Kilinç N; Tüzün Y; Daniş R; Ertem M Dig Dis Sci; 2007 Jan; 52(1):110-8. PubMed ID: 17151802 [TBL] [Abstract][Full Text] [Related]
7. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623 [TBL] [Abstract][Full Text] [Related]
8. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding. Howden CW Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118 [TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin. Pilotto A; Franceschi M; Longoa MG; Scarcelli C; Orsitto G; Perri FC; D'Ambrosio LP; Leandro G Dig Liver Dis; 2004 Oct; 36(10):666-70. PubMed ID: 15506665 [TBL] [Abstract][Full Text] [Related]
10. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. Lai KC; Lam SK; Chu KM; Wong BC; Hui WM; Hu WH; Lau GK; Wong WM; Yuen MF; Chan AO; Lai CL; Wong J N Engl J Med; 2002 Jun; 346(26):2033-8. PubMed ID: 12087138 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects. Lazzaroni M; Bianchi Porro G Dig Liver Dis; 2001 Dec; 33 Suppl 2():S44-58. PubMed ID: 11827362 [TBL] [Abstract][Full Text] [Related]
12. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin. Maiden LP; Harris AW N Engl J Med; 2002 Nov; 347(20):1623-4; author reply 1623-4. PubMed ID: 12432054 [No Abstract] [Full Text] [Related]
13. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912 [TBL] [Abstract][Full Text] [Related]
14. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Graham DY Helicobacter; 2002 Feb; 7(1):1-8. PubMed ID: 11886469 [TBL] [Abstract][Full Text] [Related]
15. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs. Naesdal J; Wilson I Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1401-6. PubMed ID: 11742186 [TBL] [Abstract][Full Text] [Related]
16. Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole. Lanas A; Rodrigo L; Márquez JL; Bajador E; Pérez-Roldan F; Cabrol J; Quintero E; Montoro M; Gomollón F; Santolaria S; Lorente S; Cucala M; Nuevo J; Scand J Gastroenterol; 2003 Jul; 38(7):693-700. PubMed ID: 12889553 [TBL] [Abstract][Full Text] [Related]
17. Low-dose aspirin: protection from the panacea. Guda N; Vakil N Am J Gastroenterol; 2002 Dec; 97(12):3202-3. PubMed ID: 12492214 [No Abstract] [Full Text] [Related]
18. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs. Langtry HD; Wilde MI Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317 [TBL] [Abstract][Full Text] [Related]
19. Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice. Leung Ki EL; Chan FK Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):163-72. PubMed ID: 22542154 [TBL] [Abstract][Full Text] [Related]
20. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. Limmer S; Ittel TH; Wietholtz H Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]